PT91415A - Processo para a preparacao de novos derivados de furiltiazol - Google Patents

Processo para a preparacao de novos derivados de furiltiazol

Info

Publication number
PT91415A
PT91415A PT91415A PT9141589A PT91415A PT 91415 A PT91415 A PT 91415A PT 91415 A PT91415 A PT 91415A PT 9141589 A PT9141589 A PT 9141589A PT 91415 A PT91415 A PT 91415A
Authority
PT
Portugal
Prior art keywords
preparation
derivatives
furiltiazole
new
ulcer
Prior art date
Application number
PT91415A
Other languages
English (en)
Other versions
PT91415B (pt
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819365A external-priority patent/GB8819365D0/en
Priority claimed from GB898905818A external-priority patent/GB8905818D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PT91415A publication Critical patent/PT91415A/pt
Publication of PT91415B publication Critical patent/PT91415B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT91415A 1988-08-15 1989-08-09 Processo para a preparacao de novos derivados de furiltiazol PT91415B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819365A GB8819365D0 (en) 1988-08-15 1988-08-15 New furylthiazole derivatives processes for preparation thereof & pharmaceutical composition comprising same
GB898905818A GB8905818D0 (en) 1989-03-14 1989-03-14 New furylthiazole derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

Publications (2)

Publication Number Publication Date
PT91415A true PT91415A (pt) 1990-03-08
PT91415B PT91415B (pt) 1995-05-04

Family

ID=26294284

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91415A PT91415B (pt) 1988-08-15 1989-08-09 Processo para a preparacao de novos derivados de furiltiazol

Country Status (12)

Country Link
EP (1) EP0355612B1 (pt)
JP (1) JP2814594B2 (pt)
KR (1) KR900003166A (pt)
CN (1) CN1040796A (pt)
AT (1) ATE109144T1 (pt)
AU (1) AU3934689A (pt)
DE (1) DE68917049T2 (pt)
DK (1) DK391089A (pt)
FI (1) FI893795A (pt)
IL (1) IL91152A0 (pt)
NO (1) NO893256L (pt)
PT (1) PT91415B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
CA2114651A1 (en) * 1991-08-02 1993-02-18 Hisashi Takasugi Furylthiazole and their use as h2-receptor antagonism and antimicrobial
GB9211163D0 (en) * 1992-05-26 1992-07-08 Fujisawa Pharmaceutical Co New oxazole derivatives
GB9326611D0 (en) * 1993-12-31 1994-03-02 Fujisawa Pharmaceutical Co New compound
DE102004008141A1 (de) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
JPWO2016098793A1 (ja) * 2014-12-17 2017-09-28 塩野義製薬株式会社 環状グアニジル基を有するチアゾール誘導体
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003640B1 (en) * 1978-01-18 1982-01-27 Imperial Chemical Industries Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
JPS5936674A (ja) * 1982-08-25 1984-02-28 Yamanouchi Pharmaceut Co Ltd Ｎ−置換グアニジノチアゾ−ル誘導体およびその製造法
JPS59225186A (ja) * 1983-05-18 1984-12-18 Yamanouchi Pharmaceut Co Ltd 新規なグアニジノチアゾ−ル誘導体及びその製造方法
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
JPS62273977A (ja) * 1986-05-21 1987-11-28 Yoshitomi Pharmaceut Ind Ltd フリルチアゾ−ル化合物
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents

Also Published As

Publication number Publication date
DE68917049D1 (de) 1994-09-01
FI893795A0 (fi) 1989-08-11
JPH0272177A (ja) 1990-03-12
EP0355612A3 (en) 1990-08-22
FI893795A (fi) 1990-02-16
JP2814594B2 (ja) 1998-10-22
EP0355612B1 (en) 1994-07-27
AU3934689A (en) 1990-02-15
EP0355612A2 (en) 1990-02-28
NO893256D0 (no) 1989-08-14
ATE109144T1 (de) 1994-08-15
PT91415B (pt) 1995-05-04
DK391089A (da) 1990-02-16
DE68917049T2 (de) 1995-01-05
KR900003166A (ko) 1990-03-23
NO893256L (no) 1990-02-16
IL91152A0 (en) 1990-03-19
DK391089D0 (da) 1989-08-09
CN1040796A (zh) 1990-03-28

Similar Documents

Publication Publication Date Title
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
DK275585A (da) Hidtil ukendte calciumsalte
ATA95989A (de) Pyridoncarbonsäurederivate und salze hievon, verfahren zur herstellung derselben und antibakterielle mittel, welche diese enthalten
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
FI885488A0 (fi) 2,2-difluorisyklopropyylietaanijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö tuholaisten torjunta-aineina
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
ES2093357T3 (es) Metodo de tratamiento de la alopecia.
ES2010161A4 (es) Utilizacion de una mezcla para el tratamiento de la alopecia
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DK284688D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
PT84130B (pt) Processo para a preparacao de novos derivados de 3-alcoxiflavonas e das respectivas composicoes farmaceuticas
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
BR8805995A (pt) Composicoes fungicidas baseadas em derivados nicotinicos,processo para preparacao de derivados nicotinicos e processo para o tratamento das doencas fungicas das plantas
BR8805994A (pt) Composicao fungicidas baseadas em derivados nicotinicos,processo para preparacao de derivados nicotinicos e processo para o tratamento das doencas fungicas das plantas
DE3685988D1 (de) Verwendung von "naftidrofuryl" zur behandlung von neuropathien.
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
RU92016264A (ru) Новые соединения, способ их получения, фармацевтический состав, его получение, способ профилактики или лечения, применение соединений
ES2052634T3 (es) Utilizacion de la 2-(2-fenil-2-(2-piridil))etil-2-imidazolina o una sal de la misma para la preparacion de una composicion farmaceutica para el tratamiento y la prevencion del asma.
ZA891583B (en) Piperazine derivative or its salt,process for producing the same and pharmaceutical composition comprising the same as active ingredient
RO94684A2 (ro) Medicament pentru tratamentul unor dermatoze
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.
ES1010920Y (es) Depuradora perfeccionado.
BR1100204A (pt) Composição farmacêutica para tratar esquizofrenia

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941007

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960430